Zensar Tech Q4 Results Review: IDBI Capital Upgrades Rating To 'Buy' On Steady Deal Wins Amid Macro Headwinds

The brokerage retains a constructive stance on Zensar Tech’s long-term prospects and revise its recommendation to Buy, assigning a target price of Rs 810 based on a valuation of 22.5 times FY27E EPS.

Zensar's revenue for the quarter stood at $156.8 million +0.9%/6.3% CC terms; TMT uptick of 1.7% QoQ and BFSI +3.4% QoQ, while, manufacturing and healthcare decline by 2.6% and 1.4% QoQ.

(Photo source: Company website)

Zensar Technologies' management re-iterated on investing in capabilities and sales team whenever there is an opportunity. Hence, maintains the guidance range of mid-teens of Ebitda margin (15-16%) going ahead.

NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

IDBI Capital Report

Zensar Technologies Ltd. posted quarterly revenue of $156.8 million, marking a modest improvement of 0.9% sequentially and 6.3% on a year-over-year basis in constant currency terms. This performance was primarily driven by sustained strength in deal wins, with order bookings consistently exceeding $200 million in recent quarters.

Management remains optimistic about the continuity of this deal momentum, anticipating it will underpin growth over the near term despite macroeconomic uncertainties. The company acknowledged emerging challenges during Q4 FY25, with expectations that these headwinds will persist into upcoming quarters.

Zensar flagged a postponement in project commencements, elongated client decision cycles, and increasingly cautious spending patterns since January.

To mitigate this, the company plans to reinvest its margin gains (above mid-teens) into business growth. Taking these dynamics into account, we retain a constructive stance on the firm’s long-term prospects and revise our recommendation to Buy (from Hold), assigning a target price of Rs 810 based on a valuation of 22.5 times FY27E earnings per share.

Click on the attachment to read the full report:

 

IDBI Capital Zensar Q4FY25 Results Review.pdf
Read Document

Also Read: Reliance Industries, RBL Bank, DCB Bank Q4 Results Review: HDFC Securities

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

lock-gif
To continue reading this story You must be an existing Premium User
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google